Bumetanide 65219-0570-04
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 26, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA216434
Need to source Bumetanide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bumetanide | .25 mg/mL |
Drug Class
Loop Diuretic [EPC]Increased Diuresis at Loop of Henle [PE]Loop Diuretic [EPC]
Selected Package
65219-0570-04Selected10 VIAL, SINGLE-DOSE in 1 CARTON (65219-570-04) / 4 mL in 1 VIAL, SINGLE-DOSE (65219-570-01)